Logo image of VMD

VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis

USA - NASDAQ:VMD - CA92663R1055 - Common Stock

6.85 USD
+0.19 (+2.85%)
Last: 10/20/2025, 8:21:04 PM
6.85 USD
0 (0%)
After Hours: 10/20/2025, 8:21:04 PM
Fundamental Rating

6

VMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. VMD scores excellent on profitability, but there are some minor concerns on its financial health. VMD is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make VMD a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

VMD had positive earnings in the past year.
VMD had a positive operating cash flow in the past year.
Each year in the past 5 years VMD has been profitable.
In the past 5 years VMD always reported a positive cash flow from operatings.
VMD Yearly Net Income VS EBIT VS OCF VS FCFVMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

1.2 Ratios

VMD has a better Return On Assets (7.57%) than 89.11% of its industry peers.
Looking at the Return On Equity, with a value of 10.00%, VMD is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
VMD's Return On Invested Capital of 7.91% is fine compared to the rest of the industry. VMD outperforms 73.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VMD is in line with the industry average of 9.33%.
The 3 year average ROIC (7.66%) for VMD is below the current ROIC(7.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.57%
ROE 10%
ROIC 7.91%
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
VMD Yearly ROA, ROE, ROICVMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

VMD's Profit Margin of 5.80% is amongst the best of the industry. VMD outperforms 81.19% of its industry peers.
In the last couple of years the Profit Margin of VMD has declined.
Looking at the Operating Margin, with a value of 6.82%, VMD is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
VMD's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 58.33%, VMD belongs to the top of the industry, outperforming 80.20% of the companies in the same industry.
In the last couple of years the Gross Margin of VMD has declined.
Industry RankSector Rank
OM 6.82%
PM (TTM) 5.8%
GM 58.33%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
VMD Yearly Profit, Operating, Gross MarginsVMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VMD is destroying value.
The number of shares outstanding for VMD has been increased compared to 1 year ago.
The number of shares outstanding for VMD has been increased compared to 5 years ago.
Compared to 1 year ago, VMD has an improved debt to assets ratio.
VMD Yearly Shares OutstandingVMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
VMD Yearly Total Debt VS Total AssetsVMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 5.98 indicates that VMD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.98, VMD belongs to the best of the industry, outperforming 86.14% of the companies in the same industry.
VMD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of VMD (0.02) is better than 82.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 5.98
ROIC/WACC0.91
WACC8.72%
VMD Yearly LT Debt VS Equity VS FCFVMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.3 Liquidity

VMD has a Current Ratio of 1.48. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
VMD has a Current ratio of 1.48. This is comparable to the rest of the industry: VMD outperforms 50.49% of its industry peers.
VMD has a Quick Ratio of 1.37. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
VMD's Quick ratio of 1.37 is in line compared to the rest of the industry. VMD outperforms 51.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.37
VMD Yearly Current Assets VS Current LiabilitesVMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.67% over the past year.
VMD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.01% yearly.
The Revenue has grown by 17.11% in the past year. This is quite good.
Measured over the past years, VMD shows a very strong growth in Revenue. The Revenue has been growing by 22.80% on average per year.
EPS 1Y (TTM)41.67%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%100%
Revenue 1Y (TTM)17.11%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%14.72%

3.2 Future

The Earnings Per Share is expected to grow by 24.89% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.73% on average over the next years. This is quite good.
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VMD Yearly Revenue VS EstimatesVMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
VMD Yearly EPS VS EstimatesVMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.15, which indicates a rather expensive current valuation of VMD.
Based on the Price/Earnings ratio, VMD is valued a bit cheaper than 70.30% of the companies in the same industry.
When comparing the Price/Earnings ratio of VMD to the average of the S&P500 Index (27.69), we can say VMD is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.98, the valuation of VMD can be described as correct.
80.20% of the companies in the same industry are more expensive than VMD, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (23.18), we can say VMD is valued slightly cheaper.
Industry RankSector Rank
PE 20.15
Fwd PE 13.98
VMD Price Earnings VS Forward Price EarningsVMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

VMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VMD is cheaper than 90.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.85
VMD Per share dataVMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VMD may justify a higher PE ratio.
VMD's earnings are expected to grow with 24.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.65
PEG (5Y)5.02
EPS Next 2Y32.27%
EPS Next 3Y24.89%

0

5. Dividend

5.1 Amount

No dividends for VMD!.
Industry RankSector Rank
Dividend Yield N/A

VIEMED HEALTHCARE INC

NASDAQ:VMD (10/20/2025, 8:21:04 PM)

After market: 6.85 0 (0%)

6.85

+0.19 (+2.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners68.04%
Inst Owner ChangeN/A
Ins Owners13.25%
Ins Owner Change1%
Market Cap265.71M
Analysts80
Price Target13.94 (103.5%)
Short Float %1.37%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)6.08%
Min EPS beat(4)-5.7%
Max EPS beat(4)32.01%
EPS beat(8)1
Avg EPS beat(8)-11.48%
EPS beat(12)3
Avg EPS beat(12)-7.67%
EPS beat(16)4
Avg EPS beat(16)-7.02%
Revenue beat(2)0
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.49%
Revenue beat(8)5
Avg Revenue beat(8)-0.39%
Revenue beat(12)8
Avg Revenue beat(12)0.05%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)0%
PT rev (3m)5.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.59%
Valuation
Industry RankSector Rank
PE 20.15
Fwd PE 13.98
P/S 1.1
P/FCF N/A
P/OCF 6.2
P/B 1.9
P/tB 2.51
EV/EBITDA 5.85
EPS(TTM)0.34
EY4.96%
EPS(NY)0.49
Fwd EY7.15%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.1
OCFY16.12%
SpS6.21
BVpS3.6
TBVpS2.73
PEG (NY)0.65
PEG (5Y)5.02
Profitability
Industry RankSector Rank
ROA 7.57%
ROE 10%
ROCE 11.16%
ROIC 7.91%
ROICexc 9.15%
ROICexgc 12.45%
OM 6.82%
PM (TTM) 5.8%
GM 58.33%
FCFM N/A
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexcg growth 3Y2.65%
ROICexcg growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score8
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA 0.08
Cap/Depr 176.74%
Cap/Sales 19.28%
Interest Coverage 25.41
Cash Conversion 100.29%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.37
Altman-Z 5.98
F-Score8
WACC8.72%
ROIC/WACC0.91
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)41.67%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%100%
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)17.11%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%14.72%
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
EBIT growth 1Y5.79%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year219.91%
EBIT Next 3Y63.61%
EBIT Next 5YN/A
FCF growth 1Y-132.43%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y26.82%
OCF growth 3Y20.23%
OCF growth 5Y15.41%